<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/123456789/412">
    <title>DSpace Community: JPTRM</title>
    <link>http://hdl.handle.net/123456789/412</link>
    <description>JPTRM</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/793" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/792" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/791" />
        <rdf:li rdf:resource="http://hdl.handle.net/123456789/790" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-19T07:22:12Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/123456789/793">
    <title>A Precise Review on Tenofovir Disoproxil Fumarate: An Analytical Profile</title>
    <link>http://hdl.handle.net/123456789/793</link>
    <description>Title: A Precise Review on Tenofovir Disoproxil Fumarate: An Analytical Profile
Authors: Chaure, Vinod A.; Ganorkar, Saurabh B.; Chaturbhuj, Ganesh U.; Surana, Sanjay J.; Shirkhedkar, Atul A.
Abstract: Tenofovir Disoproxil Fumarate (TDF) is antiretroviral medicine used treat AIDS as well as chronic&#xD;
Hepatitis-B. TDF is a prodrug of tenofovir and exists as dominant form due to lesser oral bioavailability&#xD;
of parent drug. TDF is now available in a fixed-dose combination with various antiretrovirals like&#xD;
Cobicistat, Efavirenz, Elvitegravir, Emtricitabine, Lamivudine, Rilpivirine, and Nevirapine. Hence,&#xD;
pharmaceutical analysis of TDF and applicability of different analytical methods have gained crucial&#xD;
importance. The present review article assesses the published analytical methods and a variety of&#xD;
approach for investigation of TDF in bulk drug as well as pharmaceutical formulations including&#xD;
combinations. This detailed review includes examination of around eighty analytical methods&#xD;
published during 2008 to 2016 using various techniques which include HPLC, HPTLC, and UV/&#xD;
Visible-Spectrophotometry. The review also illustrates the scope and limitations of many published&#xD;
analytical methods for analysis of TDF. Such detailed review will be of great help to the researcher who&#xD;
is working on TDF. Miscellaneous methods of rare but unique pharmaceutical distinction have also&#xD;
been given due consideration. The diagrammatic illustrations provide the statistical overview about the&#xD;
various methods referred for analysis of TDF.</description>
    <dc:date>2018-11-02T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/792">
    <title>Systemic Review: Sexual Dysfunction in Women with type 2 Diabetes Mellitus</title>
    <link>http://hdl.handle.net/123456789/792</link>
    <description>Title: Systemic Review: Sexual Dysfunction in Women with type 2 Diabetes Mellitus
Authors: Kumar, Ravinder; Gera, Diksha; Arora, Govind; Syal, Pratima K.
Abstract: Diabetes would not just have a high blood glucose level in the individual body, yet&#xD;
these days diabetes likewise goes with numerous other organic issues like hypertension,&#xD;
feeble the myocardial layer working, sexual broke, and so on. These are some real issue&#xD;
which is these days joined by diabetes to a person’s body. Guys are for the most part&#xD;
being determined to have the sexual broke issue, guys, as well as experience a sexual&#xD;
broke issue. As similarly we may see less clinical examinations, including sexual broke&#xD;
issues looked for the sort two diabetic ladies. The primary goal of this article is to&#xD;
illuminate the situation that females proceed with much trouble with regards to the&#xD;
sexual broke Complication that might be physiological or neurotic if there should arise&#xD;
an occurrence of sorting two diabetes in ladies. It chiefly involves the useful extent of&#xD;
females like sexual drive, excitement, vaginal grease, Orgasm and general fulfilment&#xD;
space. Talking about the treatmentaccess of the ailment in the analytic way for it,&#xD;
Diabetes essentially hinders the sexual execution of Diabetic Women. Determinants of&#xD;
sexual ability incorporate age and extent of diabetes.</description>
    <dc:date>2018-11-02T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/791">
    <title>Exploring RP-HPLC Method for analysis of Axitinib in Bulk and in-house Tablets</title>
    <link>http://hdl.handle.net/123456789/791</link>
    <description>Title: Exploring RP-HPLC Method for analysis of Axitinib in Bulk and in-house Tablets
Authors: Chalikwar, Shailesh S.; Kayande, Satish D.; Singh, Inderbir; Shirkhedkar, Atul A.
Abstract: Axitinib is a tyrosine kinase Inhibiter. In a commenced analysis, a effortless and responsive&#xD;
high-performance liquid-chromatography method was developed and validated for the&#xD;
quantitative estimation of Axitinib in bulk and in-house tablet dosage form. The present&#xD;
method was developed and validated using LC-GC Qualisil BDS C18(250 mm × 4.6&#xD;
mm, 5 μm). The separation of Axitinib was employed using a methanol: water 85:15%&#xD;
v/vas a mobile phase at optimal flow rate 1 mL/min and column oven temperature&#xD;
30°C. While, Axitinib was examined at 330 nm with a photo diode array detector;&#xD;
retention timewas found to be 3.23 min.The intended method was validated by ICH&#xD;
rules for the accuracy, precision, sensitivity, and ruggedness. The linearity was followed&#xD;
in the concentration range of 4 - 24 μg/mL as demonstrated by correlation coefficient&#xD;
(r2) of 0.9994. The robustness of proposed method was assessed by purposelyvarying&#xD;
the chromatographic conditions.Consequently, the intended method can routinely be&#xD;
subjected for the estimation of Axitinib in bulk and in tablets formulation.</description>
    <dc:date>2018-11-02T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/123456789/790">
    <title>Molecular Docking Studies of Phenolic Compounds from Syzygium cumini with Multiple Targets of Type 2 Diabetes</title>
    <link>http://hdl.handle.net/123456789/790</link>
    <description>Title: Molecular Docking Studies of Phenolic Compounds from Syzygium cumini with Multiple Targets of Type 2 Diabetes
Authors: Grewal, Ajmer Singh; Sharma, Neelam; Singh, Sukhbir; Arora, Sandeep
Abstract: This leads to increasing demand for natural products with antidiabetic activity with fewer side&#xD;
effects. Syzygium cumini is a traditional herbal medicinal plant and is reported to possess a variety&#xD;
of pharmacological actions. It contains various types of chemical constituents including terpenoids,&#xD;
tannins, anthocyanins, flavonoids and other phenolic compounds. Some flavonoids and other phenolic&#xD;
compounds from S. cumini were reported in literature to have type 2 antidiabetic potential. The main&#xD;
objective of the current investigation was in silico screening of some phenolic compounds from S.&#xD;
cumini against multiple targets associated with type 2 diabetes to explore the mechanism of antidiabetic&#xD;
action and prediction of binding mode using molecular docking studies. In silico docking studies were&#xD;
performed for the selected molecules in the binding site of multiple targets associated with type 2&#xD;
diabetes (α-glucosidase, dipeptidyl peptidase 4, glycogen synthase kinase 3, glucokinase and glucagon&#xD;
receptor). Amongst the compounds tested in silico, rutin showed appreciable binding with multiple&#xD;
targets of type 2 diabetes including α-glucosidase, dipeptidyl peptidase 4, glycogen synthase kinase 3,&#xD;
and glucagon receptor. Catechin was found to inhibit both α-glucosidase, and dipeptidyl peptidase 4.&#xD;
This information can be utilized for the design and development of potent multi-functional candidate&#xD;
drugs with minimal side effects for type 2 diabetes therapeutics.</description>
    <dc:date>2018-11-02T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

